The Scientist

» pharma

Most Recent

image: Welcome Back, Pharmalot

Welcome Back, Pharmalot

By | June 4, 2014

The Wall Street Journal revives the popular blog covering pharmaceutical and biotech industry news.

0 Comments

image: Pharma Buyout Tabled

Pharma Buyout Tabled

By | May 27, 2014

Pfizer says it won’t continue its pursuit to purchase AstraZeneca—at least for now.

0 Comments

image: Opinion: Sexual Dysfunction Matters

Opinion: Sexual Dysfunction Matters

By | August 19, 2013

Desire and arousal disorders require the biopharmaceutical industry’s attention.

7 Comments

image: BPTW: By The Numbers

BPTW: By The Numbers

By | June 1, 2013

Take a closer look at some of the statistics generated by The Scientist's Best Place to Work Industry 2013 survey.

0 Comments

image: Best Places to Work Industry 2013

Best Places to Work Industry 2013

By | June 1, 2013

Our final survey of the life-science industry workplace highlights the companies—small and large, domestic and international—that are making their researchers feel valued and at home.

2 Comments

image: Start It Up

Start It Up

By | April 1, 2013

Young researchers who left the academic path to transform their bright ideas into thriving companies discuss their experiences, and how you can launch your own business.

1 Comment

image: Gold Dust Missing from Pfizer Lab

Gold Dust Missing from Pfizer Lab

By | December 10, 2012

$700,000 worth of gold dust has been reported missing from a Pfizer medical research lab in Missouri.

1 Comment

image: Neurologist Reveals Insider Information

Neurologist Reveals Insider Information

By | November 26, 2012

A Michigan University clinical researcher allegedly supplied a fund manager with information about drug trial results that the fund used to rake in more than $270 million.

1 Comment

image: Opinion: Eliminating Meningitis

Opinion: Eliminating Meningitis

By | September 17, 2012

Many vaccines are on the market for various serogroups of meningococcal disease, but a solution to provide broad protection against MenB remains elusive.

1 Comment

image: Obama Signs FDA Bill

Obama Signs FDA Bill

By | July 11, 2012

The new law reauthorizes fees charged to drug and device makers, creates new fees for the approval of generic drugs.

0 Comments

Popular Now

  1. Major German Universities Cancel Elsevier Contracts
  2. Grass Routes
    Features Grass Routes

    Researchers are discovering a suite of new locations and functions of endocannabinoid receptors that play roles in sickness and in health.

  3. Studies Retracted After UCLA Investigation
  4. Trump Nominates Sam Clovis to Lead USDA Research
AAAS